Health Trials

KRAS Mutant Solid Tumors

1

Review clinical trials related to KRAS Mutant Solid Tumors. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

TLN-372 in Advanced KRAS Mutant Solid Tumors

The primary purpose of this study is to evaluate the safety, pharmacokinetics, and anti-tumor activity of TLN-372 as a single agent and in combination with other anti-tumor agents, in patients with advanced KRAS mutant solid tumors

Participants needed: 240
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Treeline Biosciences, Inc.Updated: Apr 21, 2026Locations: 11
Eligibility criteria

Patients must have measurable disease at study entry. [+3]

Patients must not have active brain metastases. [+6]

Read more